Caixin
Aug 20, 2022 08:00 AM

Beijing Leadman Biochemistry Co.,Ltd.’s Net Profit Rose 43.4% in First Half of 2022

Beijing Leadman Biochemistry Co.,Ltd. (北京利德曼生化股份有限公司) (300289.SZ) reported a net profit of 35.9 million yuan in the first half of 2022, up 43.4% year-on-year.

Meanwhile, the company posted 374.3 million yuan in revenue, up 52.4% year-on-year.

At the end of the reporting period, it had 2.3 billion yuan in total assets and 316.6 million yuan in total liabilities, with a liability-to-asset ratio of 13.7%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Business Uncovered Podcast: Inside Vanke and China’s Property Reckoning
00:00
00:00/00:00